BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24022623)

  • 1. Uncoupling PSD-95 interactions leads to rapid recovery of cortical function after focal stroke.
    Srejic LR; Hutchison WD; Aarts MM
    J Cereb Blood Flow Metab; 2013 Dec; 33(12):1937-43. PubMed ID: 24022623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats.
    Zhou HH; Tang Y; Zhang XY; Luo CX; Gao LY; Wu HY; Chang L; Zhu DY
    Stroke; 2015 May; 46(5):1352-8. PubMed ID: 25851770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors.
    Cui H; Hayashi A; Sun HS; Belmares MP; Cobey C; Phan T; Schweizer J; Salter MW; Wang YT; Tasker RA; Garman D; Rabinowitz J; Lu PS; Tymianski M
    J Neurosci; 2007 Sep; 27(37):9901-15. PubMed ID: 17855605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor.
    Bråtane BT; Cui H; Cook DJ; Bouley J; Tymianski M; Fisher M
    Stroke; 2011 Nov; 42(11):3265-70. PubMed ID: 21903963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.
    Brittain JM; Pan R; You H; Brustovetsky T; Brustovetsky N; Zamponi GW; Lee WH; Khanna R
    Channels (Austin); 2012; 6(1):52-9. PubMed ID: 22373559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSD-95 uncoupling from NMDA receptors by Tat- N-dimer ameliorates neuronal depolarization in cortical spreading depression.
    Kucharz K; Søndergaard Rasmussen I; Bach A; Strømgaard K; Lauritzen M
    J Cereb Blood Flow Metab; 2017 May; 37(5):1820-1828. PubMed ID: 27107027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSD-95 inhibitor Tat-NR2B9c (NA-1) protects the integrity of the blood-brain barrier after transient middle artery occlusion in rats by downregulating matrix metalloprotease-9 and upregulating endothelial nitric oxide synthase.
    Xu Y; Xu L; Xu C; Zhao M; Xu T; Xia L; Wu Y; Cao Y; Han Z
    Brain Res Bull; 2024 Jan; 206():110836. PubMed ID: 38042504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection after status epilepticus by targeting protein interactions with postsynaptic density protein 95.
    Dykstra CM; Ratnam M; Gurd JW
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):823-31. PubMed ID: 19535989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95.
    Fan J; Vasuta OC; Zhang LY; Wang L; George A; Raymond LA
    J Neurochem; 2010 Nov; 115(4):1045-56. PubMed ID: 20831617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calmodulin kinase IV-dependent CREB activation is required for neuroprotection via NMDA receptor-PSD95 disruption.
    Bell KF; Bent RJ; Meese-Tamuri S; Ali A; Forder JP; Aarts MM
    J Neurochem; 2013 Jul; 126(2):274-87. PubMed ID: 23363435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor.
    Bach A; Clausen BH; Kristensen LK; Andersen MG; Ellman DG; Hansen PBL; Hasseldam H; Heitz M; Özcelik D; Tuck EJ; Kopanitsa MV; Grant SGN; Lykke-Hartmann K; Johansen FF; Lambertsen KL; Strømgaard K
    Neuropharmacology; 2019 May; 150():100-111. PubMed ID: 30836092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.
    Zhou L; Li F; Xu HB; Luo CX; Wu HY; Zhu MM; Lu W; Ji X; Zhou QG; Zhu DY
    Nat Med; 2010 Dec; 16(12):1439-43. PubMed ID: 21102461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tat-NR2B9c prevents excitotoxic neuronal superoxide production.
    Chen Y; Brennan-Minnella AM; Sheth S; El-Benna J; Swanson RA
    J Cereb Blood Flow Metab; 2015 May; 35(5):739-42. PubMed ID: 25669908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excitotoxicity and focal cerebral ischemia induce truncation of the NR2A and NR2B subunits of the NMDA receptor and cleavage of the scaffolding protein PSD-95.
    Gascón S; Sobrado M; Roda JM; Rodríguez-Peña A; Díaz-Guerra M
    Mol Psychiatry; 2008 Jan; 13(1):99-114. PubMed ID: 17486105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
    Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
    Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period.
    Juan WS; Huang SY; Chang CC; Hung YC; Lin YW; Chen TY; Lee AH; Lee AC; Wu TS; Lee EJ
    J Pineal Res; 2014 Mar; 56(2):213-23. PubMed ID: 24350898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
    Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
    Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain.
    D'Mello R; Marchand F; Pezet S; McMahon SB; Dickenson AH
    Mol Ther; 2011 Oct; 19(10):1780-92. PubMed ID: 21427709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, expression, and purification of a recombinant Tat-HA-NR2B9c peptide.
    Zhou HH; Zhang AX; Zhang Y; Zhu DY
    Protein Expr Purif; 2012 Oct; 85(2):239-45. PubMed ID: 22944204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection against transient focal cerebral ischemia and oxygen-glucose deprivation by interference with GluR6-PSD95 protein interaction.
    Yu CZ; Li C; Pei DS; Zong YY; Shi Q; Wen XR; Guan QH; Hang D; Hou XY; Zhang GY
    Neurochem Res; 2009 Nov; 34(11):2008-21. PubMed ID: 19449206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.